Status:

TERMINATED

Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions

Lead Sponsor:

New Mexico Cancer Research Alliance

Conditions:

Prostate Cancer

Eligibility:

MALE

Brief Summary

To develop the hypothesis that quantitative NMR spectroscopy of human semen can be used to diagnose prostate cancer.

Detailed Description

Any willing subject who meets the male gender requirements, who is competent, agrees to participate, and is able to understand the consent form.

Eligibility Criteria

Inclusion

  • Any willing subject who meets the male gender requirements, who is competent, agrees to participate, and is able to understand the consent form.

Exclusion

  • Not sepcified.

Key Trial Info

Start Date :

October 1 2005

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2012

Estimated Enrollment :

101 Patients enrolled

Trial Details

Trial ID

NCT00250757

Start Date

October 1 2005

End Date

April 1 2012

Last Update

January 8 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of New Mexico Cancer Center

Albuquerque, New Mexico, United States, 87106

Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions | DecenTrialz